Eighteen.Efficacy and security of anticoagulants from the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-Evaluation of controlled studies. Ximelagatran, a completely new minimal-molecular-weight oral prodrug from the direct thrombin inhibitor, has proven priority about warfarin which may perhaps enable it to be the drug of choice https://sgvasculargrp.com/medical-condition/deep-vein-thrombosis/